Increased occurrence of malignancy before and after chemoradiation for anal squamous cell carcinoma: a multi-institutional analysis
Anal squamous cell carcinoma patients have an increased risk of multiple malignancies. These patients who have prior cancers have inferior outcomes. Second primary malignancy is a poor prognostic factor in patients with anal cancer. Second primary malignancy can develop years after treatment of primary anal squamous cell carcinoma.
Authors
- Lara Hathout (ORCID: https://orcid.org/0000-0003-3062-9793)
- Abraham J. Wu (ORCID: https://orcid.org/0000-0002-2597-7091)
- Harigopal Sandhyavenu
- J.R.M. Baclay (ORCID: https://orcid.org/0000-0002-8081-6928)
- Paul Bernard Romesser (ORCID: https://orcid.org/0000-0001-8268-2903)
- Chris L. Hallemeier
- Veeraswamy Manne (ORCID: https://orcid.org/0000-0002-1179-5529)
- Michael G. Haddock (ORCID: https://orcid.org/0000-0001-8966-744X)
- Erqi Liu Pollom (ORCID: https://orcid.org/0000-0003-2908-6293)
- Z. Chakrani
- Ritesh Kumar (ORCID: https://orcid.org/0000-0002-0982-6277)
- Krishan R. Jethwa (ORCID: https://orcid.org/0000-0002-7590-558X)
- Daniel T. Chang (ORCID: https://orcid.org/0000-0003-2760-1554)
- Vasilis Hristidis (ORCID: https://orcid.org/0000-0003-1442-6507)
- Salma K. Jabbour (ORCID: https://orcid.org/0000-0001-9287-6007)
- Diego A.S. Toesca
- Shou‐En Lu
Institutions
- Rutgers, The State University of New Jersey (US)
- Mayo Clinic (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of Michigan (US)
- WinnMed (US)
- Environmental and Occupational Health Sciences Institute (US)
- Michigan Medicine (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
- Rutgers Cancer Institute (US)
- Stanford University (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1093/jnci/djae309
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00